VENUS (Vascular Extensive and Numerically User-friendly Sizer) is the first software module developed by LivGemini, integrating artificial intelligence and computational modelling to provide clinicians with advanced tools in the evaluation of thoracic aortic aneurysms. The goal is clear: to standardize some of the most important clinical assessments and reduce the time required for accurate analysis of the most complex situations through a digital, intelligent and customised approach.
“Based on in-silico modelling technologies,” says Leonardo Geronzi, Founder and CEO of LivGemini,

“VENUS was created to support radiologists, cardiologists and cardiovascular surgeons in the rapid and accurate analysis of CT images, offering structured and immediate reporting. Today, analysing the evolution of an aortic aneurysm over time, especially through longitudinal CT scans,” Geronzi explains, “is a time-consuming and non-standardised activity. With VENUS, we want to simplify this process, providing a rapid and accurate tool to objectively monitor the progression of the pathology. The software automatically returns key diagnostic parameters, including maximum diameter, local curvature, volume, aortic tract length, and extent of dilatation, while also allowing for the analysis of longitudinal data to quickly obtain information about the evolution of the pathology. VENUS represents a step forward,” Leonardo Geronzi concludes, “towards a more personalised cardiovascular medicine, where automated image analysis improves the quality of clinical decisions.”
“When medical images are loaded into the software,” explains Andrea Baldini, Founder and Head of Software Development, “VENUS generates a patient-specific three-dimensional model from which the surgeon can automatically extract a big set of information to support the diagnosis in just a few seconds, using an artificial intelligence model that is not cloud-based but runs locally within the software itself. This approach speeds up and standardises anatomical analysis, reduces human error, and makes complex measurements immediately accessible. The surgeon can thus concentrate on the clinical interpretation of the data, supported by a reliable and repeatable digital model.”
“When medical images are loaded into the software,” explains Andrea Baldini, Founder and Head of Software Development, “VENUS generates a patient-specific three-dimensional model from which the surgeon can automatically extract a big set of information to support the diagnosis in just a few seconds, using an artificial intelligence model that is not cloud-based but runs locally within the software itself. This approach speeds up and standardises anatomical analysis, reduces human error, and makes complex measurements immediately accessible. The surgeon can thus concentrate on the clinical interpretation of the data, supported by a reliable and repeatable digital model.”
Designed as a user-friendly tool for direct use in hospital environments, VENUS is already being deployed in several hospitals, including the Centre Hospitalier Universitaire (CHU) of Rennes, France, where surgeons are conducting in-depth morphological analyses of the aorta and have identified new anatomical features that may help predict disease progression. Once CE certified, VENUS will operate in full compliance with GDPR and without the need to send data to external servers, ensuring data sovereignty and clinical efficiency. In addition, medical device manufacturers will subsequently be able to integrate their own catalogue into the software, offering clinicians patient-specific digital support to enhance their products, thus moving from diagnostic support to pre-operative planning support.
“LivGemini’ (www.livgemini.com) - concludes Marco Evangelos Biancolini, Founder and Business Development Manager – “was born out of direct experience at the intersection of engineering, clinical practice and simulation. It is a project developed in the field, side by side with surgeons, modelling solutions based on real-world challenges. We don't just bring technology; we build a shared language between complex algorithms and medical interpretation.
Our value lies in our ability to connect different worlds like numerical precision, clinical intuition and industrial needs into a single platform. LivGemini was not created to replace the physician, but to amplify clinical decision-making with reliable, fast, and tailored digital tools.”